Orthopedic Partners, a management services organisation serving best-in-class orthopaedic and spine surgeons, has partnered with Connecticut Neck & Back Specialists (CTNB), a leading surgical practice dedicated to comprehensive spinal disorder management located in Danbury, Connecticut.
Healthcare & Life Sciences
The IK Small Cap III Fund, alongside management, is to acquire Plastiflex Group NV (Plastiflex) from Third investors. Financial terms of the transaction have not been disclosed.
easyvet, a US-based walk-in veterinary clinic group, has closed a USD7 million Series A funding round led by Relevance Ventures.
Monroe Capital has acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of decile.ten communications (d10) by The CM Group, LLC, an existing portfolio company of NaviMed Capital.
HIG BioHealth Partners (HIG), the dedicated healthcare investment affiliate of HIG Capital, has co-led a USD52 million Series B financing round for Click Therapeutics, a pioneer in the field of digital therapeutics.
Exciva, a clinical biotech company developing a novel therapeutic compound for treating agitation/aggression in Alzheimer’s disease, has closed a Series A financing of EUR9 million (USD10 million) led by Andera Partners. LBBW Venture Capital and Cure8 also participated in the round.
Levine Leichtman Capital Partners (LLCP), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company Caring Brands International, (Caring Brands) to Wellspring Capital (Wellspring).
swissfillon, a specialist in sterile filling of complex pharmaceuticals, is joining 31 Group-backed ten23 health, a pure-play, patient-centric and sustainable biologics drug product contract development and manufacturing organisation (CDMO).
Enterprise Investment Scheme investment manager Deepbridge Capital has deployed over GBP50 million of capital into UK life sciences companies.
Click Therapeutics completes USD52m Series B Financing co-led by HIG BioHealth Partners and Accelmed Partners
Click Therapeutics (Click), a specialist in Digital Therapeutics as prescription medical treatments, has closed a USD52 million upsized Series B financing. The financing round was co-led by new investors HIG BioHealth Partners (HIG BioHealth) and Accelmed Partners II (Accelmed).